Tribal Group PLC
18 April 2005
Tribal Group plc
18 April 2005
TRIBAL GROUP ANNOUNCES STRATEGIC AGREEMENT WITH NEW YORK'S HOSPITAL
FOR SPECIAL SURGERY
Tribal Group plc ('Tribal') and the Hospital for Special Surgery ('HSS'), New
York's leading orthopaedic hospital, today announce the signing of a strategic
agreement to underline their commitment to the delivery of healthcare in the UK.
The alliance will see HSS supporting Tribal Group's wholly owned subsidiary,
Mercury Health, in the development of its treatment centre business and in
bidding for the second wave of NHS contracts.
The agreement includes the provision by HSS of advisory services and best
practice, as well as the transfer of knowledge in the area of orthopaedics. This
transfer of knowledge will be supported by an exchange programme between Mercury
Health staff and HSS staff.
The key focal areas of the agreement are patient education, advice on care
pathways, infection control and physiotherapy. HSS will also provide access to
operating processes and protocols, as well as clinical operating data.
HSS Chief Executive Officer and President, John Reynolds, who has previously
overseen the knowledge transfer of HSS's best practices in patient care and
treatment protocols for hip and knee replacements to a NHS orthopaedic centre in
London, will lead the HSS team working with and advising Mercury Health.
The strategic agreement follows a £214 million contract win by Mercury Health in
December 2004 to design, set up and manage a regional network of five treatment
centres in the South of England. These new treatment centres will perform a
range of in-patient and daycase elective surgery and diagnostic procedures for
non-acute conditions.
Henry Pitman, Chief Executive of Tribal, said:
'The strategic agreement with HSS enhances the capabilities of our healthcare
business, Mercury Health, in the delivery of elective surgery and diagnostic
procedures in the UK. By working together, we are even better placed to bid for
the second wave of NHS contracts.'
John Reynolds, Chief Executive Officer of HSS, said:
'At HSS, we perform more than 16,000 orthopaedic surgeries a year. We have
developed protocols that improve patient outcomes and simultaneously decrease
the length of patient stays and reduce costs. We expect to develop a dialogue
around these ideas in the course of this programme and look forward to working
with Mercury Health and Tribal Group.'
END
For further information, please contact:
Henry Pitman, Chief Executive, Tribal Group 01285 886020
Simon Lawton, Group Finance Director 01285 886020
Peter Martin, Chief Executive, Mercury Health 0118 925 5811
Neil Bennett/Colin Brown, Maitland 020 7379 5151
Editors' note:
Tribal Group plc provides a range of consultancy, support and managed services
to the UK public sector. The group's core markets are in education; local
government, housing and regeneration; health and social care; and central
government. The group employs 1,900 staff in the UK. Tribal is quoted on the
London Stock Exchange (TRB.L) with forecast revenues for 2006 of over £260
million.
Links: Tribal Group plc website: www.tribalgroup.co.uk/
--------------------------------------------------
Mercury Health website: www.mercuryhealth.co.uk/
--------------------------------------------------
Hospital for Special Surgery website: www.hss.edu/
----------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.